Background: Evidence suggests that general practitioners (GPs) fail to diagnose up to half of common
INTRODUCTION
Anxiety disorders are commonly diagnosed in primary health care (PHC) settings [1] , with 12-month prevalence rates varying from 8% to 20% [2] [3] [4] [5] [6] . This group of disorders is associated with impaired quality of life and compromised psychosocial functioning [7] , and the disability they cause is comparable to that of chronic physical illnesses like diabetes and hypertension [8] . They have an early onset [9, 10] and a tendency toward chronicity [11] with high comorbidity rates [12] . Additionally, they generate a great economic burden with total costs estimated at €74.4 billion or $97.4 billion (currencies converted using Purchasing Power Parity 2010 [13] ) at European level [14] .
Despite the high prevalence of anxiety disorders in PHC settings, general practitioners (GPs) still find it challenging to diagnose anxiety disorders [15] , with several studies reporting low percentages of correct anxiety disorder diagnoses in Primary Care [16] [17] [18] . Identification rates for anxiety disorders in Primary Care can be less than 50% [19, 20] , with only one third of anxiety cases being correctly diagnosed [21] and with only 33-64% of patients with an anxiety disorder receiving an accurate specific diagnosis [22] . While the recognition rate for panic disorder without and with agoraphobia is relatively high (53 and 64% respectively), the recognition rate for generalized anxiety disorder (GAD), the most prevalent anxiety disorder in Primary Care, is only 33% [22] . Furthermore, low rates of quality care have been reported in patients with anxiety disorders in PHC settings, with fewer than 10% receiving appropriate psychotherapy and with only 25% receiving antianxiety medications at a minimally adequate dose and duration [23] . Overall, two out of three patients had not received adequate psychotherapy or pharmacotherapy. When left undiagnosed and subsequently untreated, anxiety disorders can become associated with suicidal behavior [24] . Additionally, patients with undetected anxiety disorders may also undergo unnecessary, costly and potentially invasive diagnostic investigations [25] (e.g. coronary angiographies) [26, 27] , as well as unnecessary referrals to specialists (e.g., gastroenterologists, cardiologists) or visits to emergency departments in an attempt to identify nonexistent organic disorders [28, 29] . Conversely, if correctly diagnosed, anxiety disorders can be treated effectively in PHC settings [30] . This can lead to lowered healthcare costs derived from a less frequent use of healthcare resources [31] and improved clinical outcomes due to a reduction in the duration of untreated illness [32] .
Additionally, if correct diagnosis is followed by proper adherence to clinical guidelines, 35% of the economic burden of anxiety disorders can be averted [33] .
Even though some anxiety disorders can sometimes be more chronic and more impairing than mood disorders [25] , less systematic research is available on management and diagnosis of anxiety disorders in PHC compared to other mental disorders [19] . In fact, to our knowledge, no systematic reviews assessing the diagnostic accuracy of GPs' diagnoses of anxiety disorders have been performed so far. An improved understanding of GPs' diagnostic accuracy of anxiety disorders is a fundamental step in building better access to care and treatment for patients with anxiety disorders in PHC. Anxiety scales may help GPs to detect specific anxiety disorders [34, 35] , but evidence of the added value of their use over routine clinical judgment is limited. We, therefore, performed a systematic review of data on accuracy of assisted and unassisted diagnoses of anxiety disorders by GPs, worldwide, in adults and children/adolescents. We considered assisted diagnoses as diagnoses made with the help of severity scales or other diagnostic instruments and unassisted diagnoses as diagnoses made without such tools. We hypothesized that GPs' diagnostic accuracy would be higher when conducting assisted clinical interviews given that the use of clinical scales or instruments is recommended by certain clinical guidelines as a way to reinforce and guide the practitioner's clinical judgment [36] .
METHODS

This review was conducted following the guidelines of the Cochrane Handbook for Systematic
Reviews of Diagnostic Test Accuracy. A protocol was registered in PROSPERO (International Prospective Register of Systematic Reviews), under the registration number CRD42013006736.
Search strategy
We searched for articles from January 1980 to June 2014 in the following internet databases: Embase, Ovid Journals -Ovid SP Medline, Pubmed, PsycINFO (via EBSCO), Scopus, Web of Science, and Science Direct. The search terms included "anxiety disorder", "diagnosis" and "Primary Care", as controlled vocabulary and as free text. The search was initially designed in Embase and then translated to the remainder of the databases (see annex I). We also manually searched for citations in reference lists of all included articles.
Eligibility criteria and selection of studies
We included studies that reported on the ability of GPs to identify any anxiety disorder. Our definition of "any anxiety disorder" included the following disorders: panic disorder with or without agoraphobia, agoraphobia without history of panic disorder, specific phobia, social anxiety disorder, obsessive compulsive disorder, generalized anxiety disorder, anxiety disorder not otherwise specified. Subsequently, only articles that provided estimable results on measures of diagnostic accuracy in Primary Care patients were included. We also considered any type of mental disorder diagnostic procedure: based on anamnesis (unassisted, where the practitioner tries to make a diagnosis without any help from severity scales or diagnostic instruments) or assisted (where the practitioner tries to diagnose anxiety disorders with the help of any type of questionnaire or scale). Nevertheless, either assisted or unassisted, the final decision regarding the diagnosis belonged to the GP. Articles written in English, Spanish, French and German were included.
As we had an interest only in routine Primary Care attenders, we excluded studies in general population samples and studies whose Primary Care patients were selected because of a specific physical pathology or a previous or suspected diagnosis of anxiety disorders. We also excluded vignette studies and case/case-series report studies.
Data extraction
Seven members of the research team: three psychiatrists (PA, JIC, LML), two psychologists (CGF, MJBC), one pharmacist (EO) and one sixth year medical student (MR), working in pairs, independently reviewed studies found in the literature searches by examining eligibility criteria for titles and abstracts.
Discrepancies were solved through consensus or by a third reviewer. Exclusion codes were defined and registered for abstract and full-text steps. A pilot test was performed in order to homogenize criteria among reviewers. We also manually examined the reference lists of all included articles.
Data were extracted by one reviewer (EO) using a standard data extraction form and verified by a second reviewer (CGF). Any disagreements were resolved through consensus or third party adjudication, if needed. We extracted data for the following categories: study characteristics (design, main objective, country of origin, study year), participant characteristics (sample size, sex, age), GPs characteristics (number of participating GPs, age, years of clinical experience, sex, size and area of the Primary Care centre), diagnostic characteristics (source of diagnostic information, method of diagnosis, type of visit, diagnostic reference standard and criteria), and measures of diagnostic accuracy (sensitivity, specificity, prevalence, contingency table). We contacted study authors if further clarification was needed.
We assessed the quality of the included articles with QUADAS-2 tool [37] following the recommendations of the Cochrane Collaboration and of the U.K National Institute for Health and Clinical Excellence [38] . The quality of included studies, as determined by QUADAS-2, firstly entails evaluating whether the diagnostic accuracy estimates reported by the studies are free from bias (risk of bias), and secondly entails measuring the degree to which primary studies are relevant to the review's research question (applicability). This tool comprises four domains: patient selection, index test, reference standard, and flow of patients through the study and timing of the index tests and reference standard (flow and timing). The patient selection domain evaluates, in terms of risk of bias and applicability, the methods used to select patients: type of sampling, design, exclusions made and characteristics of included patients.
The index test domain determines whether the results of the index test were interpreted without knowledge of the results of the reference standard (e.g. the GPs made their diagnoses without knowing the results of the reference standard), as well as whether its conduct or interpretation varied from the ones specified in the review question. The reference standard domain assesses whether the diagnostic reference standards used in the included studies correctly classify the target disorder (anxiety disorders), if a blinded administration was used and also if "target disorder" (anxiety disorder), as defined by the diagnostic reference standard, matched the review question. The flow and timing domain tries to establish whether all patients were included in the analysis and if they all received the same reference standard.
Additionally, it determines if an adequate interval of time has elapsed between the administration of the diagnostic reference standard and the index test [37] . Each domain is judged as having "low", "high" or "unclear" risk of bias, as well as "low", "high" or "unclear" concerns about applicability. There is no overall quality score.
Statistical analysis
Whenever possible, we used the studies' reported measures of diagnostic accuracy. If this information was not provided, we constructed contingency tables using the available data. Coupled forest plots were used to report the estimated sensitivity and specificity, together with confidence intervals, in each study.
Given that heterogeneity is always to be expected in meta-analyses of diagnostic accuracy, we fitted random-effects meta-analysis models [39] . We undertook a bivariate meta-analysis. This approach preserves the two-dimensional nature of the data by analyzing together pairs of sensitivity and specificity [40] . Additionally, it incorporates any potential (negative) correlation that might exist between sensitivity and specificity within studies by using a random effects approach [40] . The parameters of the bivariate distribution were used to calculate summary estimates of sensitivity and specificity and to estimate a summary Receiver Operating Characteristic (sROC) curve. Around the summary estimates of sensitivity and specificity, we also plotted 95% confidence and prediction regions. The 95% confidence region illustrates the precision with which the summary values of sensitivity and specificity were estimated. It is drawn as an ellipse around the mean values of sensitivity and specificity. 95% prediction regions show the amount of between-study variation, reflecting the range of likely values for an individual study. They plot the particular probability of including the true sensitivity and specificity of a future study.
AUCs for the overall, assisted and unassisted pooled estimates were computed using the sROC approach with the bivariate method [41] , under the assumption of homogeneous sROC curves for computing AUCs and confidence intervals [40] .
We investigated heterogeneity by adding the following covariates: method of diagnosis, type of anxiety disorder, type of reference standard, type of instrument used, year of publication, country of origin, funding sources, objective of the study, age, disorder prevalence and specific QUADAS-2 items that raised concerns (risk of bias for patient, reference standard and flow domains, patient applicability, reference standard acceptability and blinding of the index test and reference standard). Heterogeneity was assessed with a bivariate model by including in the model each covariate at a time and testing its statistical significance with the likelihood ratio test. All analyses were run with SAS v9.1.2, with the macro MetaDAS (Proc NLMIXED) developed by The Cochrane Collaboration [39] .
RESULTS
After title review and duplicates removal, a total of 3.424 abstracts were found through database searching. Figure 1 displays the selection of studies for the meta-analysis and the exclusion reasons for every step of the review. Approximately 80% of the retrieved references, at both abstract and full-text steps, were excluded because they did not report sensitivity and specificity levels for GPs' diagnoses of anxiety disorders. Finally, 27 articles met the eligibility criteria. Review of all the reference lists of all included articles lead to two additional papers meeting all eligibility criteria. Finally, 24 articles (one article reporting data on both assisted and unassisted diagnoses) were included in the meta-analysis as five papers reported data already contained in previously included publications.
--- Figure 1 about here -----
Quality Assessment
Based on QUADAS-2 assessment (see Figure 2 ), only five of the included studies were found to have a low risk of bias in all 4 domains. The domain most susceptible to bias was the one assessing the reference standard, its interpretation and its likelihood to correctly classify anxiety disorders in case of 10 studies. 7 studies did not use an adequate reference standard and additionally the results of the reference standard were interpreted knowing the GP diagnosis in the case of two articles [42, 43] . Concerns regarding applicability were raised by the selection of patients in one article [44] where the included sample oversampled cases that screened positive at the first stage of the Primary Care Evaluation of Mental Disorders (PRIME-MD) administration (92.40% positive screen cases included in the final sample).
------ Figure 2 about here -----
Study Characteristics
Most of included studies were conducted in Europe and in the early years of the 21 st century (see Table 1 ). Determining the accuracy of GPs' diagnoses of anxiety disorders was the main research objective in case of 41.7% of included studies. 19 studies had information on funding sources with 42.1%
having being funded by a pharmaceutical company. 52.2% of the included studies gave information on unassisted diagnoses of anxiety disorders in Primary Care. The total pooled sample was 34,902 patients with a mean sample size of 1,396 per study (SD = 3,494.6). The mean age of included patients, estimated from available data, was around 48.8 years (SD = 6.94). 60.2% of included patients were women [16, 18, 34, [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] and 59.9% were either married or living with a partner [18, 34, 42, 44, 46, 47, 49, 51, [54] [55] [56] [57] . The recruited sample consisted entirely of new patients or patients with a new health problem in case of two studies [46, 53] . Another study reported that all included patients had no previous history of mental disorders [48] and in one US study 77% of the recruited individuals were established Primary Care patients [20] .
Only two studies [45, 49] reported the age profile of participating GPs and the mean estimated age was 45.8 years. The GPs' clinical experience varied from 10.3 years [53] to 17.8 years (SD=9.6) [50] . A total of 1,691 GPs participated in the studies with most of the Primary Care Centres being located in urban areas [22, 44, 47, 48, [54] [55] [56] 58, 59] . Only one study reported having included Primary Care Centres from both urban and rural areas [49] . GPs' workload was reported in two studies [18, 34] and it varied from 21.1 patients seen per day to 61. The prevalence of anxiety disorders varied from a very low 1.5% [57] to a very high 50.3% [55] with a median value of 16.4%. 69% of included studies reported data on anxiety disorders in general, with only 9 tackling a specific anxiety subtype. Out of the 20 studies presenting data on anxiety disorders three [16, 20, 47] reported results on specific subtypes of anxiety disorder as well. In terms of design, the great majority of studies were cross-sectional. Only one study was a clinical trial.
----- Table 1 about here -------Main Findings Figure 3 shows the forest plot of all included studies. Results from the Christensen et al study (FIP study) [53] were included as two different estimators because one arm of the clinical trial reported data for assisted diagnoses of anxiety disorders and the other arm for unassisted diagnoses of anxiety disorders in Primary Care. Sensitivity levels varied from a low 9% to a high 90%, whereas observed estimates of specificity were more homogeneous with a low 67% and a high 99%.
------ Figure 3 about here ------- Figure 4 .A shows the summary ROC curve of all included studies with a pooled estimate of sensitivity of 44 Figure 4 .B). The AUC for assisted diagnoses was higher than the one registered for unassisted diagnoses (AUC assisted =0.85, SE=0.03 vs. covariates as possible sources of heterogeneity, none of them was found to be statistically significant. We also investigated the existence of a possible association between diagnostic accuracy and a categorical variable that considered both the use of DSM-defined or no DSM-defined reference standards and method of diagnosis, and again no statistically significant difference was found (p-value=0.304).
DISCUSSION
Diagnosing anxiety disorders at non-specialized health care levels can be a challenging task [60] . The results of the present review show that, when diagnosing anxiety disorders, GPs' sensitivity (i.e. the ability to correctly classify an individual as "diseased") is low (44.5%) while their ability to correctly identify non-cases as not having the disorder is high (specificity 90.8%). Our results are similar to the ones Mitchell et al [61] found for depression in Primary Care: sensitivity 50.1% and specificity 81.3%.
They are also in line with other summary estimates of sensitivity of other mental disorders in Primary Care: GPs diagnostic sensitivity for alcohol use disorders was estimated at 41.7%, 95% CI 23.0 -61.7 [62] . According to our findings, GPs have difficulty in diagnosing anxiety disorders in true cases. The percentage of under recognition is even higher when diagnoses are unassisted, with a drop of almost 50% in sensitivity levels with respect to assisted diagnoses. Apparently, the impact is less noticeable on specificity levels that remain practically the same irrespective of the use of questionnaires. Additionally, the level of recognition does not seem to vary with the type of anxiety disorder diagnosed. For example, in case of generalized anxiety disorder, the estimates of sensitivity and specificity obtained (42.6%% and 85.7%% respectively) were very similar to the levels obtained for the rest of anxiety disorders combined (Sensitivity: 44.3%; Specificity 91.2%; p-value=0.445). Nevertheless, the number of studies that addressed GPs' diagnostic accuracy in different subtypes of anxiety was rather small (5 studies included in the meta-analysis). An important finding is that identification rates do not seem to change throughout the years (p-value=0.998), even though during the last few years several intervention programs have been created with the purpose of improving the quality of care for anxiety disorders in Primary Care [63, 64] .
Given the results of our study, strategies more focused on increasing the GPs' level of suspicion for the presence of an anxiety disorder might be beneficial. One possible solution might be the use of suitable screening instruments, as is the case with depression in the UK and US where screening is recommended by national guidelines [65, 66] . Several instruments for screening for anxiety disorders in Primary Care settings have been developed and used with adequate results [67, 68] . Screening for anxiety disorders in Primary Care can be a useful way to enhance recognition of these disorders and improve treatment rates and patients care [69] . Screening tools could allow identifying "high-likelihood" cases, saving an exhaustive clinical evaluation (more costly and time-consuming) for patients with a positive screen.
However, routine screening of all patients for the presence of anxiety symptoms is not recommended [70] . Other approaches have been suggested like screening for anxiety disorders only in high-risk primary care patients [71] or using case finding strategies to help the GP distinguish distress symptoms from an anxiety disorder, as the current Dutch guidelines for anxiety recommend [72] . Nevertheless, screening for anxiety disorders is necessary, but not sufficient to improve the quality of mental health care and outcomes among Primary Care patients with anxiety disorders [73] . Several studies have shown that quality of care and outcomes improve only when screening is associated with multimodel intervention programs like collaborative care [74, 75] , thus when accompanied by other changes in practice structure.
Possible explanations for our findings
Our results must be interpreted keeping in mind the particular characteristics of Primary Care. Several factors, including patient, provider and system barriers have been identified as possible problems to higher detection rates of mental disorders in Primary Care. First of all, patients might resist disclosing anxiety symptoms, either due to beliefs that personal weaknesses are the cause of their problems [76] or that pharmacological treatments [77] are harmful or simply because cultural barriers impede them to admit they suffer psychological distress [78] . Additionally, patients often present with somatic rather than emotional complaints [79, 80] , and attribute more easily their symptoms to physical causes [81] . From the provider end, different aspects can act as a barrier to adequate recognition or treatment.
These include, for example, GPs' deficient knowledge of the diagnostic procedure [82] , potential inability to read nonverbal cues [83] , or interview styles not encouraging psychosocial disclosure. Additionally, limited appointment times with little time for patient education and counseling [84] , concerns about potential patient stigma or the common belief that such diagnoses are burdensome [85] have also been pointed as potential reasons for lower recognition rates. Furthermore, physicians' beliefs and attitudes towards mental disorders have substantial influence on detection rates with lower levels in case of practitioners with negative opinions and attitudes [83] . Although simplified and specifically adapted for Primary Care, the World Health Organization (WHO) ICD-10 Primary Health Care (PHC) Guidelines for Diagnosis and Management of Mental Disorders are sometimes impractical for routine use and have uncertain impact on clinician behavior [86, 87] .
Other system barriers include productivity pressures, the lack of a systematic method for managing patients with common mental disorders [88] and inadequate continuity of care [89] .
Limitations and strengths
Our results should be interpreted in the light of several limitations. Most of the studies included in our review were cross-sectional with only 3 studies reporting a longitudinal GP assessment [16, 50, 57] . Given the fact that assessments in Primary Care have a clear longitudinal component, we cannot be sure that the disorder will not be diagnosed at a later date [90] and that diagnostic accuracy would eventually increase.
Future research should focus more on longitudinal assessment of anxiety disorders in Primary Care and also indicate, at the same time, whether undetected anxiety is important clinically, or whether it causes disability or remains undetected.
Our definition of "any anxiety disorder" did not include post-traumatic stress disorder (PTSD). We considered that the mandatory identification of a stressor/traumatic event or other causes external to the individual separated these patients into a distinctive subgroup, with a particular vulnerability.
Additionally, most PTSD studies in Primary Care were conducted on veteran populations [91] who are mainly attended in Veterans Affairs primary care clinics, a setting different from the general primary care.
Furthermore, in general primary care samples, lower prevalence rates of PTSD have been reported [92] .
Additionally, PTSD assessment of potential stressors, as defined before DSM-V, is not a strategy with high specificity when conducted retrospectively and with little relevance for establishing a probable PTSD diagnostic [93] .
Moreover, we could not adjust our results for the effect of severity of anxiety disorders, which is known to be strongly associated with detection accuracy, as only one study [50] reported levels of disorder severity in the recruited sample. Adjustment for comorbidity with depression, a frequent occurrence found in Primary Care [94] , was not possible either, because only two studies [50, 52] reported data on comorbidity of anxiety with depression. Finally, stratified analyses by age (children/adolescents, adults and elderly) initially planned in the protocol could not be performed. The presentation of anxiety may differ with age, leading to challenges in identifying it [95] . For example, elderly may tend to present with more physical symptoms [96] , while children/adolescents might lack the cognitive capabilities to report details vital to the application of the diagnostic classification system [97] . Unfortunately, none of the included studies reported data exclusively on children/adolescents and only one study was conducted on the elderly [45] . Besides, the recruited sample of two studies included both adolescents and adults [42, 47] and adolescents, adults and elderly in another two studies [18, 52] . Availability of more research on age stratified results for GPs diagnostic accuracy will provide better and unbiased estimates of recognition in Primary Care, enabling interventions in age groups with lowest diagnostic accuracy.
As reflected by the QUADAS-2 assessment, concerns were raised by the quality of the reference standards used by several studies. Non-optimal reference standards may bias the measurement of diagnostic accuracy of GPs diagnoses [98] . But it is not clear if they cause under-or over-estimation of diagnostic accuracy [98] . Nevertheless, we found no statistically significant association when analyzing as a possible source of heterogeneity the acceptability of the reference standard.
Also, for those studies that were industry funded, 62.5% reported data on assisted diagnoses whereas only 37.5% gave information on unassisted diagnoses. The role of the variable "funding" in biasing the results of clinical research has already been acknowledged, at multiple levels, in case of industrysponsored clinical trials [99] . Notwithstanding, a significant association was found between diagnostic sensitivity and a categorical variable that considered both funding and method of diagnosis information funding source and method of diagnosis cannot be excluded, with studies funded by pharmaceutical companies potentially having a higher tendency of using a more rigorous and controlled methodology.
Nevertheless, the number of studies in certain categories of the variable was again rather small.
Finally, the risk of diagnostic review bias cannot be fully excluded from our results, with a potential increase in the agreement between the reference standard and GPs' diagnoses. Even though we found no statistically significant associations between blinding QUADAS-2 variables and diagnostic accuracy, the number of studies in certain categories was low, potentially reducing the power to detect differences in diagnostic accuracy. For example, just two studies [42, 43] reported that the results of GPs' assessments were known when the results of the reference standard were interpreted and in case of another six it was unclear whether GPs diagnoses were blind to reference standard results [44, 45, 50, 51, 55, 56] . Nonetheless, our work has some strengths which lie on the extensive database search, the broad language inclusion criteria and long time period coverage. Additionally, sensitivity analyses showed that our findings are robust to the decisions made during the review process. The exclusion of a study whose participants characteristics did not fully meet the eligibility criteria (only 107 patients were from Primary Care) [56] as well as that of an abstract whose results could not be confirmed in subsequent publications [58] lead to a less than 1% change in both sensitivity and specificity levels.
CONCLUSIONS
Our data suggests that the use of adequate and brief questionnaires for case detection in Primary Care might greatly improve diagnostic accuracy, resulting in a better care for anxiety disorders in Primary Care. Moreover, GPs have favorable views regarding the use of diagnostic scales in their practice, with most of them believing that the diagnostic questionnaire assisted them in making at least one new diagnosis [100] . Improving detection rates in Primary Care may not necessarily lead to an overmedicalization of the matter and subsequently to an increase in the cost of care or of treatment. We hypothesize that most probably this increase would lead to a raise in the detection of mild cases in whom current guidelines recommend the use of low intensity interventions like cognitive behavior therapy, selfhelp programmes or psychoeducational groups [101] . Future research should bring more insight into the characteristics of the patients that go undetected, how they are treated and how they progress, as well as insight into the evaluation of the costs that these patients generate at healthcare systems level.
Consideration should also be given to possible gender differences in both diagnostic accuracy levels and unrecognized cases.
It is undoubtedly true that diagnosis alone is not enough to improve the quality of life of these patients and that future actions should also focus on better ways to manage anxiety disorders in Primary Care with multimodal intervention programs like stepped collaborative care [64, 101] . With current guidelines for depression and generalized anxiety disorder recommending treatment of the most severe problem first in case of comorbidity, steps have already been made towards a better acknowledgement of the importance of anxiety disorders in the context of other comorbid mental disorders and in other context as well. But, implementing a more balanced approach to detecting and managing anxiety in routine clinical practice takes time and it can only be done gradually.
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